Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ROCKET PHARMACEUTICALS, INC.

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT)
Listen to this Section


$2.94
+0.0240 ( +0.82% ) 1.5M

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

Market Data


Open $2.94
Previous Close $2.92
Volume 1.5M
Market Cap $318.85M
Day Range $2.89 - $3.04
52 Week Range $2.40 - $5.45
Shares Outstanding 109.19M
Change % +0.82%
Net Change ▲ 0.0240
Insider Ownership -0.05%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2015
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: 1,644,637.00

Date Type Amount Purchased Purchaser
2024-06-20 Sale -23944.00 Malik Fady Ibraham
2024-06-20 Sale -23944.00 BOESS CARSTEN
2024-05-20 Sale -113124.00 SOUTHWELL DAVID P
2024-05-20 Sale -1079.00 Militello John
2024-05-20 Sale -7979.00 Shah Gaurav
2024-05-20 Sale -2420.00 Wilson Martin
2024-05-20 Sale -3990.00 Patel Kinnari
2024-04-24 Sale -833.00 Militello John
2024-04-16 Sale -70000.00 SOUTHWELL DAVID P
2024-04-10 Sale -12532.00 White Mark Andrew

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Nov 10, 2025
4 Insider transactions 1 Oct 16, 2025
8-k 8K-related 14 Oct 14, 2025
4 Insider transactions 1 Oct 08, 2025
8-k 8K-related 12 Oct 03, 2025
8-k 8K-related 12 Oct 03, 2025
4 Insider transactions 1 Oct 03, 2025
3 Insider transactions 2 Oct 03, 2025
8-k 8K-related 12 Sep 29, 2025
4 Insider transactions 1 Sep 23, 2025

Latest News


× Before browsing our site, please accept our cookies policy